Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT06005493 · RECRUITING

Trial details

NCT number: NCT06005493
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Gastro-esophageal Junction Cancer Pancreatic Ductal Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2023-07-11
Primary completion: 2027-07-16
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.